Navigation Links
Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey
Date:10/31/2011

PRINCETON, N.J., Oct. 31, 2011 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that its central laboratory services ranked first, by a wide margin, in an independent global survey of 550 physician investigators participating in clinical trials. The majority (54 percent) of the study participants named Covance central laboratory services as their "most preferred" central laboratory, with investigators citing Covance three times more often than the nearest competitor.  Investigators also reported having the "best overall relationship" with Covance, rating it 8.4 on a scale of 1 to 10.  

The survey also determined that investigators who participate in a clinical trial with their preferred central laboratory are overwhelmingly satisfied (98 percent). When pharmaceutical sponsors select investigators' least preferred central laboratory, satisfaction drops significantly. Respondents cited central laboratory preference as a key driver of satisfaction with the pharmaceutical sponsor as well, with more than 85 percent of investigators stating that they are more satisfied and willing to work with a sponsor on trials when they have selected their preferred central laboratory.  Ninety-four percent of investigators indicate the central laboratory selected by the sponsor impacts their (and their staffs') success, day-to-day activities, and willingness to work with a particular sponsor on future studies.

Survey results showed that factors that lead to a strong relationship between investigators and a central laboratory include effective communication, the laboratory's reputation for reliability and quality, and easy-to-use collection kits. Respondents ranked Covance first in all of the key performance metrics, from customer service to timely and accurate reporting.

"We make every effort to understand the challenges investigators face and tailor our opera
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
2. Covance Receives Highest Level of Phase I Accreditation
3. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2009 Financial Results Conference Call
4. Covance to Present at the 28th Annual J.P. Morgan Healthcare Conference
5. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
6. Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
7. Covance to Present at Piper Jaffray 21st Annual Health Care Conference
8. Covance To Present At The 20th Annual Global Healthcare Services Conference
9. Covance To Present at the Deutsche Bank 35th Annual Health Care Conference
10. Covance to Present at Goldman Sachs 31st Annual Global Healthcare Conference
11. Covance to Present at William Blair & Companys 30th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015 The March 3, 2015, order from the ... change their products, labels to clarify the drugs, intended use ... stroke is necessary to protect the public from injury from ... at Simmons Hanly Conroy . The order ... the products – currently taken by millions of U.S. men ...
(Date:3/4/2015)... , March 4, 2015 XBiotech ... pilot study in patients with moderate to severe ... The open-label Phase II trial evaluated the potential ... antibody that targets interleukin-1 alpha (IL-1a). IL-1a is ... cells present in skin lesions. The Company claims ...
(Date:3/4/2015)... 4, 2015   Mayo Clinic and ... the next generation of wearable biosensors designed to fight ... this technology will be game-changer. These patch biosensors may ... James Levine, M.D., Ph.D. , a Mayo Clinic ... and can be integrated into the care people receive." ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
(Date:3/4/2015)... CA (PRWEB) March 04, 2015 ... supports American military service members during and after their ... a Cause,” will increase awareness through advertising, social media ... funds for the patriotic organization through a special retail ... Sauvignon wines from March through May 2015. , ...
(Date:3/4/2015)... 2015 In a small ceremony with 20 ... their new facility in New Port Richey on February 24, ... facility will allow the Florida drug detox facility ... abuse epidemic through treatment and education. “Due to our unique ... the United States, we made the decision that expanding our ...
(Date:3/4/2015)... March 04, 2015 The Conrad N. ... a total of $6.9 million, which will help 151,000 ... and Burkina Faso. , The programs cover three years ... will focus on fixing water points in disrepair, addressing ... local people to maintain water points and ensuring safe ...
(Date:3/4/2015)... March 04, 2015 Problem Gambling Awareness ... to join individuals and organizations across the nation in ... public, health care professionals, policymakers, and others about problem ... on Compulsive Gambling (FCCG) and FCCG partner organizations are ... screen patients for a gambling problem, to make treatment ...
(Date:3/4/2015)... March 04, 2015 Follow us ... is driven by the increasing incidence of CNS disorders, ... of late stage drugs. The unmet medical needs for ... untapped potential in the market. Presently, there exists an ... overcome the limitations of current generation drugs. Companies are ...
Breaking Medicine News(10 mins):Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 2Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:Problem Gambling - A Public Health Issue; March Is Problem Gambling Awareness Month 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4
... Oct. 24 (HealthDay News) -- The 30-year-old woman arrived at the ... coughing blood. It didn,t take long for doctors to figure ... at a hotel five days prior at which she -- and ... and various body parts. The silicone was not the ...
... Project Muscular Dystrophy (PPMD) in 1995 to link families, like ... resources and hope. Now, Furlong has blazed a new trail ... a partnership between PPMD and the Public Library of Science ... this month. The story of the partnership is told in ...
... may be what the doctor orders to help patients ... recently published scientific paper, higher levels of physical exercise ... ocular perfusion pressure (OPP), an important risk factor for ... Visual Science journal (Physical Activity and Ocular Perfusion ...
... , MONDAY, Oct. 24 (HealthDay News) -- A researcher has ... that she says may be the first anatomical marker for ... came in for a persistent cough, Dr. Barbara Stewart used ... and the airways that branch into the lungs -- and ...
... years ago, Sheri Scott was beginning a new chapter ... browsing bridal magazines and busy planning for her big ... diagnosed with breast cancer. Suddenly, she was juggling ... a wedding. Soon after her diagnosis, Scott was approached ...
... MA Age- related macular degeneration (AMD) is the ... Researchers had previously identified several relatively common genetic variants ... but a significant number of persons without the disease ... investigators have been able to clearly show a specific ...
Cached Medicine News:Health News:Illegal Silicone Buttock Injections Can Be Deadly: Experts 2Health News:Illegal Silicone Buttock Injections Can Be Deadly: Experts 3Health News:Patient advocacy groups turn to open-access publishing to advance research quest 2Health News:Physical fitness could have a positive effect on eye health 2Health News:Could Airway Abnormality Point to Autism? 2Health News:Could Airway Abnormality Point to Autism? 3Health News:Life beyond cancer: Starting a family following treatment 2Health News:Life beyond cancer: Starting a family following treatment 3Health News:Researchers ID genetic mutation associated with high risk of age-related macular degeneration 2
Unipolar Ventricular Lead...
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
Steroid-eluting, screw-in pacing lead...
... are small profile endocardial permanent pacing leads ... lead body size of only 4.8 F ... F, the Physique lead is the smallest ... in both straight and pre-formed J configurations, ...
Medicine Products: